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The Mouth Disintegrating Extended Release Telmisartan 
(MDERT) tablets are designed for adequate pharmacokinetic 
profile to avoid the unusual peaks and troughs. Although, there 
are extensive advance techniques used to deliver drugs. But oral 
route is still remains effective in most of the therapeutical 
situations. Thus we aimed this study to formulate a dosage form 
with dual character of orodispersion as well as extended 
effectiveness. MDERTS dosage form was prepared by direct 
compression method. The major components of this preparation 
were Telmisartan (TLM), Carboxy methyl cellulose polyvinyl 
Pyrrolidone, Chitosan, Talc, Mg-stearate, Lactose. The MDERTS 
dosage form was characterized with different determinants. 
While, the drug release curves of all 6 formulations upto 12h, 
DSC spectra of TLM, Kyron T134, Primogel, TLM+Kyron 
T134+Primogel, Chitosan, CMC and different excepients are 
presented as comprehensive scientific figures. DSC and FTIR 
spectroscopic studies indicate the compatibility of drugs with 
each other and with excipients. Moreover, the formulation F2 
containing more than 10% of Kyron T had shown best results. 
Whereas, the overall results had shown that Kyron T containing 
tablets had best, in vitro dispersion time, wetting time and 
wetting volume, water absorption ratio. The order in which 
superdisintegrants and polymers had produced desirable effect is 
Kyron T134 > Kyron  T134134 + primogel > primogel and for 
polymers chitosan> chitosan+CMC> chitosan +PVP> CMC> 
CMC+PVP> PVP. Thus, Kyron T is the best superdisintegrant of 
others which were used in present study and direct compression 
method is the best used to prepare extended release mouth 
disintegrating tablets.   
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INTRODUCTION  
Orally disintegrating Telmisartan (TLM) 
tablet with extended release profile is intended 
to assure the drug compliance with minimal 
adverse effects. The Mouth Disintegrating 
Extended Release Telmisartan (MDERT) 
tablets are designed for sustained therapeutic 
benefits along with adequate pharmacokinetic 
profile to avoid the unusual peaks and troughs 
(Allen and Remington, 2012)  
Moreover, the chitosan is carbohydrate 
and its source is skeleton of shellfish, also some 
other sources may includes shrimp and crab, 
used in different pharmaceutical preparations, 
act as cationic natural polysaccharides have 
diverted considerable attention to its diverse 
applications as renewable nontoxic bio 
degradable polymer. (Ravi et al., 2004) Polyvinyl 
Pyrrolid one (PVP), also commonly called 
povidone, is a polymer and its polymeric units 
are N-vinylpyrrolidone. Polyvinyl Pyrrolidone is 
used in different pharmaceutical industries as 
PV-expander (plasma volume expander) for 
patients with trauma. The most widely used 
oldest disintegrant, the starch is provided with a 
dramatic disintegrating properties and are 
available as Explotab® and Primogel.(Ieva et 
al., 2009) 
It is chemically cross-linked and 
carboxymethylated potato starch. It is 
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manufactured by cross-linking starch with 
sodium trimetaphosphate followed by 
carboxymethylation with sodium mono-
chloroacetate. Approximately one glucose 
monomer unit in every four is substituted. 
(Shanmugam, 2015) 
Whereas, the Kyron -T134  is   basically 
derivative of polymer- polyacrylic acid in cross 
linking form used for taste masking  and 
stabilization of drug in different pharmaceutical 
industries. It is whitish in color and swells upon 
contact with water. Different vitamins may 
deteriorate on storage e.g vitamin B12, so their 
stabilization demands Kyron -T134.   
Although, there are extensive advance 
techniques used to deliver drugs. But oral route 
is still remains effective in most of the 
therapeutical situations. Oral dosage forms also 
having problems in swallowing because more 
than 35% of population is arrested in such 
problem and such problem is associated with 
many pathological problems like. (Belal et al., 
2014) Thus, Mouth Disintegrating TLM 
(MDT’s) Tablet with Extended Release Profile 
can be recommended for parkinsonism, motion 
sickness, senseless patient, patients with old 
age, mentally disabled persons, unavailability of 
water and children. The superdisintegrants and 
polymers were compressed directly to produce 
the MDT’s. The main objectives of this study 
were to formulate an antihypertensive extended 
release MDT’s with dual character of 
orodispersion as well as extended effectiveness. 
The active superdisintegrants and polymers 
may have desired pharmaceutical 
characteristics, suitable in challenging 
environment during travelling or situations of 
unavailability of water. Hence, we have 
formulated MDT’s that having mechanical 
strength in prescribed range. That can be 
manufactured expediently with existing 
conventional machinery. The formulation is 
target cost-effective and has constant and 
uniform outcomes.  
Hence, the pharmacy professionals are 
still working to formulate an ideal ODT’s with 
sustained therapeutic effect for many hours. 
That may potentially minimize the irregular 
fluctuations in plasma that may effects the 
required therapeutic outcomes. Therefore, 
MDERTs   have   dual benefits of immediate as  
well as sustained therapeutic effect. MDERT’s 
also have comparatively lower dose, frequency 
and adverse effects with better economical 
benefits. (Bankars et al., 2014) 
  
MATERIAL AND METHODS 
This research study was conducted in 
Hitech Lab., and Department of 
Pharmaceutics, Faculty of pharmacy, University 
of Sargodha, Pakistan during June, 2014 to 
February, 2015. The major equipments used 
were included FTIR (IR Prestige 21 Shimadzu), 
Thermal Analyzer (SDT Q600), Oven (IM-30 
IRMECO Gmb), Spectrophotometer UV 1700 
(Shimadzu), Micropipettes, pH meter (Jenway 
3510), Friabilator (Pharma test, Germany), 
Weight balance (Shimadzu A x200), Dissolution 
Apparatus (Pharma test) and Disintegration 
Apparatus (Pharma test). whereas the major 
materials used during experimental work were 
T134134 (Qantar Pharmaceuticals), TLM 
(Highnoon Laboratories), Carboxy Methyl 
Cellulose (Vision Laboratories), Mg-stearate 
and talc were (Willson Pharmaceuticals, Lactose 
(Welcare Pharmaceutical), Chitosan (Highnoon 
Laboratories), Primogel (Bosch 
Pharmaceuticals), Polyvinyl Pyrrolidone (S.B 
pharmaceuticals), Saccharine sodium and 
flavors (Saffron Pharmaceuticals). 
 
Direct compression method 
All the desired materials such as drug, 
polymers, superdisintegrants and other 
excipients required for extended release 
orodispersible tablets were weighed accurately 
on scientific electronic weighing balance (Table 
I). 
The two portions of all six formulations 
were designed as extended release and 
orodispersible. The materials were weighed on 
electrical balance and then passed through sieve 
No 40. These were homogenized in tumbling 
cylindrical mixer for 10 minutes at a speed of 
15rpm. Then a wet mass of this mixture was 
prepared by adding a suitable amount of water 
to produce granules. Granules were dried at the 
temperature of 60°C over the night. Then 
granules were brought so that to be passed 
through a sieve of mesh No.80 to receive 
granules of desired size. At the end we mixed 
both   portions   of  weighing  materials  for  06 
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formulations to homogenize in tumbling 
cylindrical mixer for 20min and compressed 
into extended release orodispersible tablets by 
using ZP 19 station rotary tablet compressing 
machine. (Ieva et al., 2009)  
 
Pre and post compression Determinants  
The flow properties were investigated by 
measuring the bulk and tapped density. Other 
pre-compression determinants were Bulk 
density, tapped density, angle of repose aor, 
carr’s compressibility index, and hausner’s ratio. 
While the post-compression determinants were 
thickness, weight variation, hardness and 
friability, wetting time, water absorption ratio, 
drug content, in vitro drug release, and in vitro 
disintegration time.  
 
Study Design  
MDERTS dosage form was prepared 
with ambition of to get dual effects; producing 
immediate as well as sustain therapeutic effect. 
Direct compression method used for it. The 
major components of this preparation were 
TLM, Carboxy methyl cellulose polyvinyl 
Pyrrolidone, Chitosan, Talc, Mg-stearate, 
Lactose. While the equipments and instruments 
used to study the parameters were FTIR (IR 
Prestige 21 Shimadzu),   Thermal Analyzer 
(SDT Q600), Oven (IM-30 IRMECO Gmb), 
Spectrophotometer UV 1700 (Shimadzu), 
Micropipettes,    pH    meter   (Jenway  3510), 
Friabilator (Pharma test, Germany), Weight 
balance (Shimadzu A x200) , Weight balance 
(Shimadzu A x200), Disintegration Apparatus 
(Pharma test), Aluminum foil, Platinum             
loop, Spatula, Beakers. Finally, we have 
characterized the MDERTS dosage form        
with different determinants- Bulk density, 
Tapped density, Angle of repose, Carrs index, 
Hausners ratio, Thickness, Weight variation, 
Hardness, Weight variation, Wetting time, 
Wetting volume, Water absorption ratio,            
Drug content, In vitro drug release, In vitro 
disintegration time etc. The final results of 
Angle of Repose, Bulk density, Tapped  
density, Hausner’s Ratio and Carr’s Index, 
Hardness, Weight variation,  Thickness, 
Friability, Disintegration time and Wetting                  
time has been tabulated to illustrate the     
finding. While, the drug release curves of                 
all 6 formulations upto 12h, DSC spectra of 
TLM, Kyron T134, Primogel, TLM+Kyron 
T134+Primogel, Chitosan, CMC and different 
Table I.  Formulations of mouth disintegrating and extended release portions of formulations. 
 
Mouth disintegrating portion of formulation 
Ingredients (mg) F1 F2 F3 F4 F5 F6 
TLM 40 40 40 40 40 40 
Pre-gelatinize Starch 16 - 12 08 04 - 
Kyron T134 - 16 04 08 12 - 
Mg-Stearate 04 04 04 04 04 04 
Talc 04 04 04 04 04 04 
Lactose 77 77 77 77 77 93 
Orange Flavor 05 05 05 05 05 05 
Saccharine Sodium 04 04 04 04 04 04 
Total Weight(mg) 150 150 150 150 150 150 
Extended release portion of formulation.  
TLM 40 40 40 40 40 40 
CMC 20 - - 20 20 - 
Chitosan - 20 - 20 20 20 
PVP - - 20 - -20  
Mg-Stearate 04 04 04 04 04 04 
Talc 04 04 04 04 04 04 
Lactose 82 82 82 82 82 82 
Total Weight(mg) 150 150 150 150 150 150 
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excepients are presented as comprehensive 
scientific figures.  
 
Formulations Criteria  
The factors that determine the best 
formulation were the disintegration time, 
invitro dispersion time, wetting time of finished 
dosage form, wetting volume of preparation, 
water absorption ratio, drug release curve or 
cumulative %age drug release, performance of 
superdisintegrants for better disintegration 
properties, water absorption ratio for tablets 
depends upon the method of preparation and 
concentration of superdisintegrants, nature of 
excipients and method of tablets preparation 
and tablet strength that determine the 
dissolution  
 
Statistical Analysis  
The computer software SPSS used for 
statistical ANOVA (Analysis of Variance) 
analysis. That is applied to design, develop and 
formulate be best possible mouth disintegrating 
TLM tablet with extended release profile using 
response surface methodology.  
 
RESULT AND DISCUSSION  
Powder blend was prepared for 06 
formulations by using different concentrations 
of sustained release edible polymers and 
superdisintegrants. These formulations were 
characterized for rheological properties such as; 
Carr’s Index, Hausner’s Ratio Angle of Repose, 
Tapped Density and Bulk Density. Bulk density 
and tapped density of 06 formulations was 
found in the range of 0.613 to o.627g/mL and 
0.721 to 0.749g/mL respectively. Angle of 
Repose of 06 formulations was noted to be           
in the range of  21.6 to 24.5 (ϴ). Hausners 
Ratio of 06 formulations was noted to be in the 
range of 1.16 to 1.20%. Carr’s Index of 06 
formulations was found in the range of 17.55 to 
19.50 % .These results of powder blend are 
well within specified limits (Table II). 
This powder blend was used to make 
Extended release ODTs of TLM by as 
discussed. These tablets were evaluated for 
different parameters recommended for 
extended release MDTs. The results of 
hardness, weight variation, thickness and 
friability are present within the pharmacopeial 
limits ( Table III, IV).  
Table Fourier Transform Infrared 
(FTIR) spectroscopy 
Fourier transform infrared spectroscopy 
can be used to analyze the individual pure 
expedients (Bankars et al., 2014) and in 
combination (formation). The FTIR spectra of 
TLM alone and in combination with 
superdisintegrants and polymers were taken to 
check any interaction between drug molecules 
as well as with superdisintegrants (Figure 1). 
The spectrum of FTIR had shown that there 
was complete presence of characteristic peaks 
of drug molecules and excipients. It means that 
there was no interaction between and drug 
excipients.  
The FTIR spectrum of pure TLM 
showed the prominent peak of the drug at 
3400cm-1 of O-H stretching of – COOH acid 
and other peaks at 2960cm-1 due to C-H 
stretching vibration of aromatic group, -OH 
bending and – C=O stretching of – COOH 
acid at 1385cm-1, C=C stretching of aromatic 
group at 1600cm-1 and functional group of          
(-COOH) at 1697cm-1 (Figure 2). FTIR spectra 
of TLM with excipients and excipients with 
each other also shown that same characteristic 
peak were present as single spectra of drug and 
excipients (Figure 3). 
Our formulations contain Kyron  T134 
and primogel in combination in different ratios. 
The release data of all 06 formulations had also 
shown that chitosan has best retarding 
properties than PVP and CMC. The order in 
which superdisintegrants and polymers had 
produced desireable effect is shown as under 
Kyron T134>Kyron  T134 + primogel> primogel 
and for polymers chitosan> chitosan+CMC> 
chitosan+PVP> CMC> CMC+PVP> PVP. 
Our findings are in line with Lepek et al., 
(2013), who reported TLM (TLM) as a poor 
water-soluble angiotensin II receptor antagonist 
in crystalline form. That was transformed into 
the amorphous state by the melt quench 
technique, as well as a cryogenic grinding 
method, in order to improve its physiochemical 
properties. The chemical stability of TLM, that 
is, the tendency of the material to resist change 
or decomposition due to internal reaction, or 
due to the effects of air, heat, light, pressure, 
etc., during formation of the amorphous phase 
was assessed by monitoring high performance 
liquid chromatography.  Measurements of the 
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physical properties and dissolution tests of G4 
formulations tablets with TLM in crystalline 
and amorphous form after different storage 
periods were also performed. 
Finding of this study are also 
substantiated by Rao et al. (2011), who reported 
a simple and rapid reversed phase liquid 
chromatographic method for separation and 
determination of the related substances of TLM 
was developed and validated. he related 
substances relate to a novel synthetic route and 
different from those A-H impurities reported 
by European Pharmacopeia. 
Moreover, Zong et al. (2013) reported 
the solid dispersion systems of TLM with 
biopolymer carrier chitosan have been 
investigated in this study. The mechanism of 
solubilization of chitosan for drug has been 
studied. In addition, the influence of several 
factors was carefully examined, including the 
preparation methods, the drug/carrier weight 
ratios,  and  the milling  time. Drug  dissolution 
and physical characterization of different binary 
systems were studied by in vitro dissolution 
test, particle size distribution, Fourier transform 
infrared   spectroscopy,   differential   scanning 

















F1 298.68 4.2 4.12 0.718±0.02 76±2.00 90±1.50 
F2 295.90 3.9 3.94 0.587±0.00 42±0.60 52±1.30 
F3 299.25 3.8 4.15 0.591±0.02 67±1.50 58±1.50 
F4 300.20 4.1 4.10 0.782±0.01 56±0.30 69±0.83 
F5 298.50 3.9 4.25 0.769±0.02 49±2.00 61±1.50 
F6 299.55 5.0 4.16 0.642±0.01 Up to hrs No much wetting 
 












F1 25±0.50 68±1.00 6.8 0.90±0.15 
F2 17±1.50 44±1.15 6.7 1.30±0.20 
F3 24±0.50 61±1.00 7.3 1.00±0.10 
F4 22±1.50 57±1.53 6.8 1.10±0.03 
F5 20±0.50 51±1.00 6.6 1.20±0.10 
F6 No such  absorption Up to hrs 7.3 No such  absorption 
 
Table IV. Results of angle of repose, bulk density, tapped density, hausner’s ratio and carr’s index. 
 
Code 
Bulk Density     
(g/mL) 
Tapped Density                   
(g/mL) 
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calorimetry, powder X-ray diffractometry, and 
scanning electron microscopy. As a result, a 
significant effect of chitosan increasing TLM 
dissolution has been demonstrated, and 
cogrinding in a roll ball mill was the best way to 
prepare solid dispersions, which had high 
degree of uniformity in drug content and had a 
practical application in manufacturing. 
Additionally Sekar et al. (2008) reported 
the TLM as an insoluble in water; hence the 
drug may be slowly or incompletely dissolved 
in the gastro intestinal tract. So the rate of 
dissolution and therefore its bioavailability                
is less (bioavailability 42%). In the present 
study an attempt has been made to           
prepare immediate release tablets of TLM by 
using Polyplasdone XL-10 (Crosspovidone) at 
intragranular, extragranular and partly intra            
and extragranular level of addition to increase 
the rate of drug  release  from  dosage  form to 
 
 




Figure 2. DSC spectra of drug with different excipients.  
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Spectra of Chitosan 
 
Spectra of CMC 
 
Spectra  of  PVP  spectra of TLM + chitosan + PVP + 
CMC 
 
Spectra of TLM 
 
Spectra of Kyron T134 
 
spectra of Primogel 
 
spectra TLM+Kyron T134+Primogel 
 
spectra of chitosan +PVP+ CMC+ Kyron  T134+ Primogel 
 
Figure 3. FTIR Spectra of  TLM, Kyron T134, Primogel, TLM+Kyron T134+Primogel, Chitosan, 









Figure 2. DSC spectra of drug with different excipients.  
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increase the dissolution rate and bioavailability. 
The prepared granules and tablets were 
evaluated for their physiochemical properties 
and in-vitro dissolution study was conducted 
for the prepared tablets. Moreover, the 
immediate release tablets with proper hardness, 
disintegration time and with increase rate of 
dissolution can be made using Polyplasdone 
XL-10. Formuation-10 (F10) was selected for 
stability study and the in-vitro dissolution study 
showed that was no difference in percent of 
drug released between initial and sixth month 
sample (Hafeez et al., 2013). 
 
CONCLUSION 
The determinants of MDERTS can be 
adjusted with the acceptable range to improve 
the biological efficiency. DSC and FTIR 
spectroscopic studies indicate the compatibility 
of drugs with each other and with excipients. 
Moreover, the formulation F2 containing more 
than 10% of Kyron T had shown best results. 
Whereas, the overall results had shown that 
Kyron T containing tablets had best, in vitro 
dispersion time, wetting time and wetting 
volume, water absorption ratio. In addition of 
that the rheological properties of blend powder 
are modifiable and improvable to meet the 
quality standard specifications for MDERTS. 
The order in which superdisintegrants and 
polymers had produced desirable effect is 
Kyron T134 > Kyron  T134134 + primogel > 
primogel and for polymers chitosan> 
chitosan+CMC> chitosan +PVP> CMC> 
CMC+PVP> PVP. Thus, Kyron T is the best 
superdisintegrant of others which were used in 
present study and direct compression method is 
the best used to prepare extended release 
mouth disintegrating tablets. 
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